Gibson, Sarah E. http://orcid.org/0000-0003-2427-6442
Dojcinov, Stefan
Dotlic, Snjezana http://orcid.org/0000-0002-2036-9206
Hartmann, Sylvia http://orcid.org/0000-0003-3424-1091
Hsi, Eric D.
Klimkowska, Monika http://orcid.org/0000-0002-3391-930X
Melle, Federica http://orcid.org/0000-0001-8032-5128
Pileri, Stefano A.
Ramsower, Colleen A. http://orcid.org/0000-0002-4991-7712
Rech, Karen http://orcid.org/0000-0001-6770-2339
Rimsza, Lisa M. http://orcid.org/0000-0003-1268-2750
Rodriguez-Pinilla, Socorro Maria http://orcid.org/0000-0002-2191-1327
Tousseyn, Thomas A. http://orcid.org/0000-0002-0397-1086
de Jong, Daphne http://orcid.org/0000-0002-9725-4060
Sabattini, Elena http://orcid.org/0000-0002-4136-3591
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (5‰ n.21198)
Associazione Italiana Contro le Leucemie - Linfomi e Mieloma
Article History
Received: 21 February 2023
Revised: 3 April 2023
Accepted: 21 April 2023
First Online: 2 August 2023
Declarations
: LMR is a named inventor on a patent filed by the National Cancer Institute (“Methods for determining lymphoma type”).
: This study was conducted with the approval of the Institutional Review/Ethics Boards of Mayo Clinic, IEO, and by the Medical Ethical Committee of AmsterdamUMC/VUMC (registration 2020.343).
: The authors declare no competing interests.